Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Summary & key facts

This paper is a wide review of how ketamine and the chemicals the body makes from it work in the brain and body. The authors describe ketamine's uses as an anesthetic, a pain reliever, an anti-inflammatory, and a fast-acting antidepressant in some studies. They explain that ketamine is broken down quickly into several metabolites, and one group of those metabolites (called hydroxynorketamines or HNKs) showed antidepressant-like effects in animal studies. The review also covers common side effects like dissociation, memory or thinking problems, and the drug's potential for misuse. The main idea is that figuring out which parts of ketamine and its breakdown products cause the helpful effects could help design safer medicines with the same benefits.

Key facts:

• Ketamine has been used in medicine since about 1970 for anesthesia. It produces a kind of anesthesia where people feel detached rather than fully unconscious.
• At typical anesthetic doses, ketamine usually does not cause the serious breathing problems that some other anesthetics can cause.
• Researchers report that ketamine can relieve pain, reduce inflammation, and produce rapid antidepressant effects in some clinical studies, sometimes within hours to days after a controlled low dose.
• After you get ketamine, the body quickly breaks it down into several metabolites, including norketamine and hydroxynorketamine (HNK).
• In animals, certain HNK metabolites showed antidepressant-like effects, which suggests those breakdown products might help explain ketamine’s mood effects. But this has not been proven in people yet.
• Ketamine works on many brain targets. Its anesthetic and pain effects are largely linked to blocking NMDA receptors — a brain molecule that helps nerve cells communicate and change — but other systems such as GABA, dopamine, serotonin, opioid receptors, and certain ion channels may also be involved.
• Common short-term side effects include dissociative or hallucination-like experiences, problems with memory or thinking, and a risk of recreational misuse. The review also notes that long-term effects are not fully understood.
• The authors say that understanding which parts of ketamine or its metabolites cause the good effects and which cause side effects could help develop new drugs that keep benefits while reducing harms.

Topics

Neuroscience and Neuropharmacology Research Treatment of Major Depression Tryptophan and brain disorders

Categories

Health Sciences Medicine Pharmacology

Tags

Analgesic Anesthesia Anesthetic Antidepressant Chemistry Dissociative Drug Hippocampus Internal medicine Ketamine Medicine NMDA receptor Pharmacology Phencyclidine Psychotomimetic Receptor

Substances

Ketamine

Conditions & symptoms

Anxiety Chronic Pain Depression PTSD Chronic pain Sadness or low mood